Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of MIR101 or MIR128 in the treatment of seizure disorders

Use of MIR101 or MIR128 in the treatment of seizure disorders

US Patent 11761006 · Granted Sep 19, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of treating developmental disorders with gaboxadol2025
Use of (s)-3-amino-4-(difluoromethylenyl) cyclopent-1-ene-1-carboxylic acid and 2025
Methods and compositions for treatment of epileptic disorders2024
Methods and compositions for treatment of epileptic disorders2024
Methods of treating seizure disorders and Prader-Willi syndrome2024
Methods and compositions for treatment of epileptic disorders2024
Methods and compositions for treatment of epileptic disorders2024
Methods and compositions for treatment of epileptic disorders2023
Use of (1S,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid an2023
Use of gaboxadol for the treatment of non-24 hour sleep-wake disorder2023
Use of (S)-3-amino-4-(difluoromethylenyl) cyclopent-1-ene-1-carboxylic acid and 2023
Methods and compositions for treatment of epileptic disorders2022